OVERVIEW

2nd Personalized Medicine Conference is organized by Fusion Conferences Ltd and would be held during Mar 17 - 20, 2017 at Fiesta Americana Condesa Cancun, Cancun, Quintana Roo, Mexico to discuss precision diagnostics, cancer genomics, biomarkers, computational imaging, bioinformatics and data analytics/big data.

The target audience for this medical event basically for Scientists and physician-scientists in academia, biotech and pharmaceutical companies who would like to gain a better understanding in any of the above areas or engage in discussions on state of the art in each of these areas. Specifically, researchers working in clinical research or clinical development, biomarkers, translational research, precision therapeutics, clinical genomics, and computational biology will find this conference very appealing.

Objectives :

Develop a deeper understanding of key research questions, challenges, approaches and results in each of the topics. The Personalized Medicine conference participant will hear key findings and future directions for research in each topic.

Educational Need :

The personalized medicine space has been defined by recent regulatory approvals of targeted therapeutics in oncology and co-developed diagnostics used in patient selection. However, a broader view of personalized medicine encompasses other disease areas, newer therapeutic regimens, new therapeutic platforms and broad computational approaches. This conference will weave together many of these new approaches and their relevance to personalized medicine.

KEY DATES

Event Start Date
17 Mar, 2017
Event Start Date
Event End Date
20 Mar, 2017
Event End Date

SPECIALITIES

OncologyBioinformatics

SUGGESTED HOTELS

CONFERENCE VENUE

LocationFiesta Americana Condesa Cancun All Inclusive
Boulevard Kukulcan km 16.5, Zona Hotelera

RELATED CONFERENCES & LIVE WEBINARS

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Oncology
30 CME
...
More actions
GB£19

Feb 01 - 02, 2027 | Dubai, Dubai, UAE

Pathology
30 CME
...
More actions
GB£45

Oct 29 - 30, 2026 | Orlando, Florida, USA

Oncology
More actions
US$235